Potential and problems of developing transdermal patches for veterinary applications

Advanced Drug Delivery Reviews

Volumn 50, Issue 3, 2001, Pages 175-203

  Riviere, Jim E ^a   Papich, Mark G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Fentanyl; Iontophoresis; Transdermal drug delivery; Veterinary drug delivery

Indexed keywords

DRUG DOSAGE; INSECTICIDES; SKIN;

LIQUID 'POUR-ON' FORMULATIONS; TRANSDERMAL PATCHES;

VETERINARY MEDICINE;

ALPRAZOLAM; ANTHELMINTIC AGENT; ATENOLOL; BUPRENORPHINE; CARBAMATE INSECTICIDE; CHLORINATED HYDROCARBON; CYTARABINE; DRONABINOL; ENALAPRIL; EPTAZOCINE; ETHINYLESTRADIOL; FIPRONIL; IMADACLOPRID; ISOSORBIDE DINITRATE; KETOPROFEN; KETOROLAC TROMETAMOL; KETOTIFEN; NORETHISTERONE; ORGANOPHOSPHATE INSECTICIDE; PESTICIDE; PRASTERONE; PRAZOSIN; PYRETHROID; SALBUTAMOL; SELAMECTIN; SELEGILINE; TERFENADINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VETERINARY DRUG;

ANIMAL DISEASE; ARTICLE; BODY MASS; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; EPIDERMIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN FUNCTION; SKIN PENETRATION; SPECIES DIFFERENCE; TRANSDERMAL PATCH;

EID: 0035452136     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00157-0     Document Type: Review

References (78)

1. Comparative anatomy, physiology, and biochemistry of mammalian skin
2. Anatomical factors affecting barrier function
3. Epidermal lipids, barrier function, and desquamation
4. Effect of humidity and occlusion on the percutaneous absorption of parathion in vitro
5. The effects of vasoactive drugs on transdermal lidocaine iontophoresis
6. 14C cortisol in man
7. Cutaneous laser Doppler velocimetry in nine animal species
8. Interspecies and interegional analysis of the comparative histological thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species
9. Skin permeability in vivo
10. Evaluation of animal models for predicting skin penetration in man
11. In vivo animal models for percutaneous absorption
12. Topical drug delivery to cattle and sheep
13. Pharmacokinetics of skin penetration
14. Physico-chemical determinants of skin absorption
15. Mathematical models of percutaneous absorption
16. The prediction of transdermal permeation: Mathematical models
17. Pharmacokinetic implications of changing blood flow in skin
18. Parathion metabolism during percutaneous absorption in perfused porcine skin
19. Percutaneous absorption, dermatopharmacokinetics, and related biotransformation studies of carbaryl, lindane, malathion and parathion in isolated perfused porcine skin
20. Percutaneous absorption, biotransformation and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model
21. Percutaneous absorption of topical parathion through porcine skin: In vitro studies on the effect of environmental perturbations
22. Review of the 1993 Veterinary Drug Bioequivalence Workshop
23. Correlation between stratum corneum reservoir function and percutaneous absorption
24. The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: Influence of the application time
25. The isolated perfused porcine skin flap (IPPSF): II. Ultrastructural and histological characterization of epidermal viability
26. Comparison of an in vitro skin model to normal human skin for dermatological research
27. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies
28. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology
29. Isolated perfused porcine skin flap as an in vitro model for predicting transdermal pharmacokinetics
30. A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap (IPPSF)
31. Quantitative prediction of transdermal iontophoretic delivery of arbutamine in humans using the in vitro isolated perfused porcine skin flap (IPPSF)
32. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexylphthalic acid and ρ-aminobenzoic acid in the isolated perfused porcine skin flap compared to man
33. Development of surgical techniques for preparation of in vitro isolated perfused porcine skin flaps for percutaneous absorption studies
34. A 'full-space' method for predicting in vivo transdermal plasma drug profiles reflecting both cutaneous and systemic variability
35. Cutaneous metabolism of isosorbide dinitrate after transdermal administration in isolated perfused porcine skin
36. Residue avoidance after topical application of veterinary drugs and parasiticides
37. Dermal absorption and toxicity assessment
38. Inert ingredients in pesticide formulations influence the dermal absorption of carbaryl
39. Veterinary applications of skin penetration enhancers
40. Chloropyrifos toxicosis in cats and cattle
41. Percutaneous absorption of organophosphate insecticides in pigs - The influence of different vehicles
42. 14C]coumaphos after dermal application to lactating goats as a pour-on formulation
43. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature
44. Enhancing or blocking effect of fenvalerate on the subsequent percutaneous absorption of pesticides in vitro
45. Percutaneous absorption of parathion and its metabolites paraoxon and p-nitrophenol administered alone or in combination: In vitro flow through diffusion cell system
46. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically-exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin
47. 14C-ring-2,6-parathion in vivo in pigs
48. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in vivo in swine
49. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically-exposed chemicals. II. Development of a general dermatopharmacokinetic model for use in risk assessment
50. Deconvolution study of the absorption rate and disposition kinetic values of lindane in sheep
51. Residues of lindane in plasma and fat of sheep after dipping
52. Disposition of transdermally administered fentanyl in dogs
53. Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs
54. A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery
55. Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs
56. Absorption characteristics of transdermally administered fentanyl
57. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats
58. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats
59. Electrically-assisted transdermal drug delivery
60. Model systems in iontophoresis - Transport efficacy
61. Transdermal iontophoretic peptide delivery. In vitro and in vivo studies with luteinizing hormone releasing hormone (LHRH)
62. The effects of vasoactive drugs on transdermal lidocaine iontophoresis
63. Pulsatile transdermal delivery of LHRH using electroporation. Drug delivery and skin toxicology
64. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory species